Valuation : Mesa Laboratories, Inc.

Market Cap 677M 583M 552M 500M 939M 64.64B 943M 6.56B 2.52B 32.89B 2.54B 2.49B 104B P/E 2027 *
54.8x
P/E 2028 * 36.2x
Enterprise Value 677M 583M 552M 500M 939M 64.64B 943M 6.56B 2.52B 32.89B 2.54B 2.49B 104B EV / Sales 2027 *
2.65x
EV / Sales 2028 * 2.5x
Free-Float
94.38%
Yield 2027 *
0.53%
Yield 2028 * 0.53%
1 day+0.70%
1 week-4.20%
Current month-4.27%
1 month+10.05%
3 months+14.03%
6 months+51.87%
Current year+55.94%
1 week 120.69
Extreme 120.69
127.18
1 month 103.94
Extreme 103.94
132.7
Current year 71.06
Extreme 71.065
132.7
1 year 59.44
Extreme 59.44
132.7
3 years 55.45
Extreme 55.45
155.12
5 years 55.45
Extreme 55.45
333.42
10 years 55.45
Extreme 55.45
333.42
Manager TitleAgeSince
Chief Executive Officer 57 12/04/2026
Director of Finance/CFO 58 29/10/2012
Comptroller/Controller/Auditor 41 01/01/2022
Director TitleAgeSince
Chairman 73 01/09/2017
Director/Board Member 58 04/03/2019
Director/Board Member 57 11/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
15/8/26 Exercice

Director

5,568 0.0995%
15/8/26 Exercice

Director

5,568 0.0995%
15/8/26 Exercice

Chairman

5,568 0.0995%
Change 5-day change 1-year change 3-year change Capi.($)
+0.86%-4.20%+94.02%-3.89% 677M
-1.39%-5.90%-23.15%-0.50% 179B
-1.09%-3.51%-3.60%+11.62% 117B
+0.11%-3.07%+5.94%+80.49% 61.25B
-1.92%-7.24%+9.51%+41.28% 50.24B
+0.15%-4.17%-7.09%-33.74% 48.05B
-1.91%-5.61%+9.17%-22.67% 31.89B
+0.09%-11.81% - - 28.42B
+1.40%+2.68%+32.35%-12.11% 24.23B
+0.49%-8.98%-13.28%+5.27% 21.4B
Average -0.35%-5.17%+11.54%+7.31% 56.22B
Weighted average by Cap. -0.84%-4.25%-6.01%+10.77%

Financials

2027 *2028 *
Net sales 255M 220M 208M 189M 354M 24.39B 356M 2.47B 951M 12.41B 959M 938M 39.21B 270M 233M 220M 200M 375M 25.82B 377M 2.62B 1.01B 13.14B 1.02B 993M 41.51B
Net income 13.27M 11.43M 10.82M 9.81M 18.4M 1.27B 18.5M 129M 49.43M 645M 49.82M 48.73M 2.04B 21.13M 18.21M 17.24M 15.63M 29.32M 2.02B 29.47M 205M 78.74M 1.03B 79.37M 77.63M 3.25B
Net Debt - -
Logo Mesa Laboratories, Inc.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Employees
717
Date Price Change Volume
12/09/26 USD 122.41 +1.24% 86,811
10/09/26 USD 120.91 -2.42% 171,655
09/09/26 USD 123.91 +0.14% 127,796
08/09/26 USD 123.74 -3.16% 148,555
04/09/26 USD 127.78 -0.58% 100,597
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
120.91USD
Average target price
117.50USD
Spread / Average Target
-2.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MLAB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!